@ThunderC4T Taking your analogy to its logical conclusion Novartis are dead, cut up into pieces, drowned in wine and cooked with a lot of vegetative matter and MSB are still growing strongly and developing its full potential.
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-408
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
-0.045(4.48%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 94.0¢ | $5.470M | 5.657M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7725 | 96.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.5¢ | 77830 | 17 |
View Market Depth
| Last trade - 11.39am 31/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |